Manufacturers shall clearly indicate on the label that the instructions for use of the device are supplied in electronic form instead of in paper form.
That information shall be provided on the packaging for each unit or, where appropriate, on the sales packaging. In the case of fixed installed medical devices, that information shall also be provided on the device itself.
In the case of software, the information shall be provided at the location from where access to the software is granted.
Manufacturers shall provide information on how to access the instructions for use in electronic form.
That information shall be provided as set out in the second subparagraph of paragraph 1 or, if not practicable, in a paper document supplied with each device.
The information on how to access the instructions for use in electronic form shall also contain the following:
any information needed to view the instructions for use;
the Basic UDI-DI and/or the UDI-DI of the device, as respectively referred to in Article 27(6) and Article 27(1), point (a)(i), of Regulation (EU) 2017/745, and any additional information allowing the identification of the device, including its name and if applicable the model;
relevant manufacturer contact details e.g. manufacturer’s name, address, email address or other means of online communication and website;
where and how instructions for use in paper form can be requested and within which time they shall be obtained at no additional cost in conformity with Article 5, point (3).
Where, for devices and accessories referred to in Article 3(1), point (a), a part of the instructions for use is intended to be provided to the patient, that part shall not be provided in electronic form.
The instructions for use in electronic form shall be available entirely as text, which may contain symbols and graphics, with at least the same information as the instructions for use in paper form. Video or audio files may be provided in addition to the text.